By Bonnie Eslinger (June 10, 2022 at 9:57 p.m. EDT) — A California judge gave a final say in a lawsuit with investors in which he accused GoodRx of inflating the health technology company’s share price by breaking news of a competing Amazon program hidden in it and said a revised lawsuit filed Thursday was missing facts showing the defendants knew about the competitor’s plans.
In his nine-page ruling, US District Judge David Carter said the lack of new evidence again nullified investors’ claims.
“Had the plaintiffs presented any direct evidence of GoodRx’s alleged knowledge — such as
Stay ahead of the curve
In the legal profession, information is the key to success. You need to know what’s happening with customers, competitors, operations, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Access to case data in articles (numbers, files, courts, type of action and more.)
- Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
- Create custom alerts for specific article and case topics, and more!
TRY LAW360 FREE SEVEN DAYS
Comments are closed.